Content area

|
|

Genomisk medicin og kræft

Forfatter(e)
Stig E. Bojesen1, 2 1) Klinisk Biokemisk Afdeling, Herlev og Gentofte Hospital 2) Institut for Klinisk Medicin, SUND, Københavns Universitet

Ugeskr Læger 2019;181:V12180852
Reference: 
Ugeskr Læger 2019;181:V12180852
Blad nummer: 

Stig E. Bojesen:

Genomic medicine and cancer

Ugeskr Læger 2019;181:V12180852

Our genomic understanding of cancer evolves quickly, driven by technological advances. Insights are added every day, but their interpretations are based on fundamental hypotheses on heredity and cell biology formulated more than 100 years ago. Genomic medicine is already in some use, but data from extremely large experiments of 100,000s of patients, controls, and tumours will alter the whole management of cancer; from early detection programmes before diagnosis, to efficient diagnostics, targeted treatment, response surveillance and monitoring of relapse.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Marianne Puge Nielsen | 13/11
1 Kommentar
af Akil Raad Kami Abdel-Wahab Walli | 13/11
6 kommentarer
af Larry Højgaard Kristiansen | 11/11
1 Kommentar
af Sven Refslund Poulsen | 09/11
3 kommentarer
af Christian Crüger | 06/11
1 Kommentar
af Anders Christiansen | 05/11
1 Kommentar
af Thamilini Umaramanan | 05/11
2 kommentarer